Market Cap : 4.75 B | Enterprise Value : 4.62 B | PE Ratio : | PB Ratio : 38.39 |
---|
NAS:EIDX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:EIDX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Eidos Therapeutics's Repurchase of Stock for the three months ended in Sep. 2020 was $0.00 Mil.
Eidos Therapeutics's Repurchase of Stock for the trailing twelve months (TTM) ended in Sep. 2020 was $0.00 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.
Repurchase of Stock for the trailing twelve months (TTM) ended in Sep. 2020 was 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) = $0.00 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline